Updated duration of response for patients receiving dostarlimab plus carboplatin-paclitaxel treatment compared with patients receiving placebo plus carboplatin-paclitaxel in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial. - Mirza, Mansoor; Willmott, Lyndsay; Hietanen, Sakari; Gilbert, Lucy; Myers, Tashanna; Balázs, Boglárka; Pennington, Kathryn; Bauerschlag, Dirk; Miller, Eirwen; Boere, Ingrid; Buttin, Barbara; Edelson, Mitchell; et al. (Gynecologic Oncology, 2025)